In contrast, our results and those of others suggests that expression of tumor PD-L1 positively correlates with higher TIL [37, 38], a better response to neoadjuvant chemotherapy [39], and improved overall outcomes in some types of breast cancer [20–23]. Here, CD274 is linked to breast cancer.